News & Publications for:

Timothy Miller

Protein production is an early biomarker for RNA-targeted therapies

Posted on October 31, 2018

Wade K. Self, Kathleen M. Schoch, Jacob Alex, Nicolas Barthélemy, James G. Bollinger, Chihiro Sato, Tracy Cole, Holly B. Kordasiewicz, Eric Swayze, Randall J. Bateman, Timothy M. Miller. Annals of Clinical and Translational Neurology 2018 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty: ,

Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism

Posted on September 4, 2018

Erin G Conlon, Delphine Fagegaltier, Phaedra Agius, Julia Davis-Porada, James Gregory, Isabel Hubbard, Kristy Kang, Duyang Kim, The New York Genome Center ALS Consortium. eLife, Volume 7, 13 July 2018, Article number e37754 Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, NeuroRestorative Therapy, Publications Faculty:

Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models

Posted on August 21, 2018

Alex McCampbell, … and Timothy M. Miller. Journal of Clinical Investigation, Volume 128, Issue 8, 1 August 2018, Pages 3558-3567 Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, NeuroRestorative Therapy, Publications Faculty:

New ALS therapy in clinical trials

Posted on July 17, 2018

Drug extends survival, reverses some neuromuscular damage in animals Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, NeuroRestorative Therapy, News Faculty:

Miller receives Essey award from neurological society

Posted on May 7, 2018

Recognized for advancing research into ALS Read More

Posted in: Clocks & Sleep, HPAN, Neurodegeneration, NeuroRestorative Therapy, News Faculty: